Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

162 results
Display

An Anesthetic Management of a Patient with Parkinson's Disease Who Underwent Whipple's Operation by Enteral Levodopa Administration

Kang WJ, Oh JY, Kim KS, Kim DO, Kim DS

Parkinson's disease is a relatively common neurologic disorder that afflicts approximately 1% of the population over 50 years old. Many drugs currently used for the treatment of Parkinson's disease may...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Case mimicking Neuroleptic Malignant Syndrome associated with Levodopa Withdrawal in Parkinson's Disease

Park HJ, Kim TH, Kim JE, Lee BR, Lee SJ, Oh GS

  • KMID: 2065593
  • J Korean Neurol Assoc.
  • 2005 Oct;23(5):721-723.
No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Seniors with Parkinson's Disease: Initial Medical Treatment

Ahlskog JE

Parkinson's disease most often presents after age 60, and patients in this age group are best managed with levodopa therapy as the primary treatment modality. Unlike young-onset parkinsonism (onset
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Case of Dopamine Dysregulation Syndrome and Repetitive Behavior Caused by Levodopa in Parkinson's Disease

Huh SY, Kim MJ

Levodopa treatment in Parkinson's disease (PD) can cause a wide range of non-motor manifestations including poor impulse control and stereotyped behaviors. Punding is a term used to describe complex prolonged,...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Effects of Long-term Levodopa Treatment to Depression in Parkinson's Disease

Choi CH, Lee JH, Sohn YH, Kim JS

  • KMID: 2016246
  • J Korean Neurol Assoc.
  • 1997 Aug;15(4):783-789.
Depression is frequently accompanied in idiopathic Parkinson's disease, and there were many researches about the pathogenetic mechanism of the depression. Recently the depression is thought to be developed by endogenous...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Does 3-O-Methyldopa(3-OMD) Inhibit the Binding of Levodopa to Plasma Protein

Bae JW, Harder S

  • KMID: 1554205
  • Korean J Psychopharmacol.
  • 1999 Oct;10(2):180-184.
OBJECTIVE: We determined the influence of 3-OMD in the protein binding of levodopa to estimate the effect of 3-OMD on the penetration of levodopa into brain. METHOD: P-glycoprotein in the brain...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Psychosis in Parkinson

Koh SB, Park KW, Lee DH

  • KMID: 1944956
  • J Korean Soc Biol Psychiatry.
  • 1997 Jun;4(1):132-135.
Current treatment strategies for levodopa-induced psychosis in advanced Parkinson's disease have had limited success. Reduction or discontinuation of levodopa and coadministration with dopamine-blocking neuroleptics may attenuate the psychotic symptoms, but...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Liquid Levodopa/Carbidopa: Old Solution, Forgotten Complication

Vijiaratnam N, Cheng S, Bertram KL, Williams D

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Long-Term Therapeutic Efficacy of Levodopa in Parkinson's Disease

Choi IS, Choi YC, Heo JH, Lee SS, Kim JH, Lee MS

  • KMID: 2138113
  • J Korean Neurol Assoc.
  • 1993 Jun;11(2):181-186.
We evaluated the therapeutic effects and complications of 118 patients with idiopathic parkisonism who were receiving levodopa therapy for more than 1 year. Response to therapy and complications of drug...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Residual Motor Disability After Levodopa Supplement in Parkinsonian Patients

Sohn YH

  • KMID: 2342475
  • J Korean Neurol Assoc.
  • 1995 Jun;13(2):256-262.
It has been reported that the antiparkinsonian efficacy of levodopa is reduced after long-term administration However, main parkinsonian motor symptoms, since they are mainly caused by the deficiency of nigrostriatal...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Two Families of Diunally Fluctuating Hereditary Progressive Dystonia

Kim JW, Cho GS, Myung HJ

  • KMID: 1957459
  • J Korean Neurol Assoc.
  • 1990 Dec;8(2):389-392.
Diurnally fluctuating hereditary progessive dystonia is a rare movement disorder characterized by marked diurnal fluctuation of symptoms and dramatic response to levodopa. We report two advanced female patients of two...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Effect of Levodopa on Akinetic Mutism in Bilateral Anterior Cerebral Artery Infarction: A case report

Kim DY, Park CI, Ohn SH, Lim JY

  • KMID: 2324527
  • J Korean Acad Rehabil Med.
  • 2007 Apr;31(2):238-242.
Akinetic mutism is a clinical syndrome in which the patient is unable to speak (mutism) or move (akinesia). Various brain lesions can induce akinetic mutism. We attended a 71-year-old woman...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Less Pulsatile Levodopa Therapy (6 Doses Daily) Is Associated with a Reduced Incidence of Dyskinesia

Lin MM, Laureno R

OBJECTIVE: To evaluate whether less pulsatile levodopa therapy (LPT) can reduce the development of levodopa-induced dyskinesia (LID). METHODS: This is a retrospective cohort study of patients with Parkinson’s disease at the...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Risk Factors for Cognitive Impairment in Patient with Parkinson's Disease Treated with Levodopa

Kim KS, Lee KE, Lee MK

BACKGROUND: Long-term levodopa therapy relieves the motor dysfunction associated with Parkinson's disease (PD), but has various effects on non-motor symptoms, including cognitive dysfunction, hallucinations, and affective disorders, and can exacerbate...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Association between Parkinson's Disease and Helicobacter Pylori

Çamcı G, Oğuz S

Helicobacter pylori (HP) is a common infection of the gastrointestinal system that is usually related to peptic ulcers. However, recent studies have revealed relationships between HP and many other diseases....
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Effect of Levodopa on Visual Function in Amblyopia

Lee JH, Choi DG

  • KMID: 2123506
  • J Korean Ophthalmol Soc.
  • 1996 Aug;37(8):1354-1359.
Recently many attempts have been made to find a meaical treatment for amblyopes who failed or were stable to respond to conventional occlusion therapy. To evaluate the efficacy and tolerability...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Amantadine as Treatment for Levodopa-Induced Dyskinesia

Jung JI, Cha JK, Kim SH, Kim JW

  • KMID: 2065448
  • J Korean Neurol Assoc.
  • 2000 Sep;18(5):562-567.
BACKGROUND: Dyskinesia is a common side effect complicating long-term levodopa therapy for Parkinson's disease. However, the pathogenesis of dyskinesia has not been completely understood. In recent animal studies, it has...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Levodopa-induced Thrombocytopenia

Oh JY, Lee JY, Lee YH, Kim YS, Sohn EH, Lee AY

  • KMID: 2185070
  • J Korean Neurol Assoc.
  • 2008 Aug;26(3):247-249.
Drug-induced thrombocytopenia can be caused by various medications and should be suspected in any patients with newly developed thrombocytopenia. We report a patient with severe thrombocytopenia induced by L-dopa. This...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Subthalamic Deep Brain Stimulation for Parkinson's Disease

Lyoo CH, Chang JW, Lee MS

  • KMID: 1572446
  • J Korean Neurol Assoc.
  • 2006 Jun;24(3):191-203.
The recent progress in the basic knowledge of basal ganglia pathways and advances in the techniques of the neuroimaging studies enabled subthalamic deep brain stimulation (STN DBS). In Korea, more...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Dopa-responsive Dystonia Misdiagnosed as Cerebral Plasy: A Case Report

Kim SS, Sohn SK, Kim JW, Chang YS

  • KMID: 2105578
  • J Korean Orthop Assoc.
  • 1999 Aug;34(4):769-772.
Dopa-responsive dystonia (DRD) is a slowly progressive dystonia with childhood onset and is characterized by marked diurnal fluctuation of symptoms, dramatic response to levodopa treatment and concurrent signs of parkinsonism....
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr